News

Keep up to date with our news, press releases, and recent announcements.

Press News WATS3D® AI Platform Included in American Gastroenterological Association (AGA) Clinical Practice Update on New Technology and Innovation for Surveillance and Screening in Barrett’s Esophagus SUFFERN, NY (August 25, 2022) — CDx Diagnostics, Inc. announced that the WATS3D view, published in Clinical Gastroenterology and Hepatology. WATS3D …
Press News Avalon Healthcare Solutions’ Client BCBS of South Carolina Adds CDx Diagnostics as In-Network Lab SUFFERN, NY (June 14, 2022) – CDx Diagnostics, Inc. is pleased to announce that it has signed an agreement with laboratory benefits management …
Press News CDx Diagnostics’ WATS3D Participates in Highmark, Inc. Health Plans in Delaware, Pennsylvania, and West Virginia Highmark, Inc. joins numerous payors in creating positive medical policy for WATS3D and opening participation in their networks.
Press News New Research Shows Progression to Esophageal Cancer as Detected by WATS3D SUFFERN, NY (February 22, 2022) — A newly published study as lead article in Gastrointestinal Endoscopy shows that Barrett’s esophagus (BE) and …
Press News CDx Diagnostics’ WATS3D Receives “Medically Necessary” Designation from Highmark Health Plans Highmark Blue Cross Blue Shield, Highmark BCBS Delaware, and Highmark BCBS West Virginia join numerous payors in creating positive medical policy for …
Press News WATS3D Receives Medically Necessary Designation from Blue Cross Blue Shield of Kansas City Kansas City joins Hawaii Medical Services Association, BCBS South Carolina, and Avalon in considering WATS3D a covered benefit
Press News WATS3D Now Considered Medically Necessary by BlueCross BlueShield of South Carolina SUFFERN, NY, Jan. 26, 2021 (GLOBE NEWSWIRE)) – WATS3D, an AI-powered diagnostic platform developed by CDx Diagnostics to identify precancerous and …
Press News CDx Diagnostics Awarded Federal Supply Schedule Contract Veterans now have access to WATS3D life-saving technology in the VA and community settings   SUFFERN, NY (December 15, 2020) – CDx Diagnostics has …
Press Study Confirms WATS3D as Cost-Effective Adjunct to Seattle Protocol The addition of WATS3D to the screening process for BE resulted in approximately 3 fewer cancers and 3 fewer cancer deaths per 1,000 people screened

Get the latest posts in your email.

order kits Icon

Order Kits

Request additional test kits or patient materials.

Order Now

support icon

Support

Let us help you with questions about our products and services. 

Request Support

lab services icon

Laboratory Services

Learn about the diagnostic assessments used in evaluating specimens.

Learn More